Pulse Biosciences, Inc.
PLSE
$17.19
$0.704.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.36% | -52.88% | -11.39% | -12.29% | 15.05% |
| Total Depreciation and Amortization | -1.39% | -2.38% | -1.34% | -0.33% | -1.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.44% | 128.00% | 45.32% | 16.66% | -47.60% |
| Change in Net Operating Assets | -185.26% | 730.26% | -40.44% | 137.51% | -214.16% |
| Cash from Operations | -47.87% | -1.33% | -7.49% | 14.16% | -44.21% |
| Capital Expenditure | 15.09% | -39.47% | -31.03% | -480.00% | 88.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 15.09% | -39.47% | -31.03% | -480.00% | 88.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -69.32% | -21.96% | 475,615.38% | -95.74% | -62.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -205.36% | 120.14% | -- | -- |
| Cash from Financing | -69.28% | -22.13% | 23,458.11% | -186.89% | -62.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -96.82% | -26.18% | 708.09% | 8.34% | -57.45% |